Christian Streck to Neuroblastoma
This is a "connection" page, showing publications Christian Streck has written about Neuroblastoma.
Connection Strength
1.475
-
Interferon-mediated anti-angiogenic therapy for neuroblastoma. Cancer Lett. 2005 Oct 18; 228(1-2):163-70.
Score: 0.228
-
Adeno-associated virus vector-mediated systemic delivery of IFN-beta combined with low-dose cyclophosphamide affects tumor regression in murine neuroblastoma models. Clin Cancer Res. 2005 Aug 15; 11(16):6020-9.
Score: 0.226
-
Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth. J Pediatr Surg. 2005 Jan; 40(1):236-43.
Score: 0.216
-
Restriction of neuroblastoma angiogenesis and growth by interferon-alpha/beta. Surgery. 2004 Aug; 136(2):183-9.
Score: 0.210
-
Longterm recombinant adeno-associated, virus-mediated, liver-generated expression of an angiogenesis inhibitor improves survival in mice with disseminated neuroblastoma. J Am Coll Surg. 2004 Jul; 199(1):78-86.
Score: 0.209
-
Endostatin-mediated concomitant resistance in neuroblastoma. J Pediatr Surg. 2004 Mar; 39(3):405-11; discussion 405-11.
Score: 0.204
-
Avoiding misdiagnosing neuroblastoma as Wilms tumor. J Pediatr Surg. 2008 Jun; 43(6):1159-63.
Score: 0.068
-
Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US. Radiology. 2006 Jul; 240(1):73-81.
Score: 0.060
-
Careful decoy receptor titering is required to inhibit tumor angiogenesis while avoiding adversely altering VEGF bioavailability. Mol Ther. 2005 Feb; 11(2):300-10.
Score: 0.054